Become an evidence partner for the AI-governed pharma QMS
Verified under our SDLC — the customer validates intended use. A 90 day controlled GMP evidence sprint: one workflow, one inspection-defensible evidence package, founder-led.
Built for the regulatory world taking shape now — FDA CSA Final Guidance (Feb 2026) · EU AI Act phasing 2026–2027 · EU GMP Annex 22 (Draft 2025). MIRA stays advisory, with a human in the loop on every GxP-critical decision.
A paid ladder, not a free trial
Three steps, each one earning the next. Start small with an evidence map, run a founding-partner pilot, then roll it into a Year-1 license — with your pilot fee credited back in full.
Evidence Mapping
$3.5K · ₹3L + applicable GST
10 business days
We map one GMP workflow end-to-end and scope the evidence needed to make it inspection-defensible. The entry point for Emerging / Clinical Biotech.
Paid Pilot
100% credited to your Year-1 license
$11K · ₹9L + applicable GST
90 days
A controlled evidence sprint on one live workflow. You leave with a configured workflow and one inspection-defensible evidence package — founder-led throughout. For Mid-Market & Enterprise engagements.
License
Year-1 ACV from $15K–$1.5M+ · ₹10L–₹8Cr + applicable GST
Pilot credit applied
Roll the pilot into a Year-1 license. AI is bundled across pilot and license — no token meter, no per-use overage.
Inspection-defensible deliverables — yours at the end of the pilot.
Everything you build in the sprint is yours to keep. Not slideware — a documented workflow and an inspection-defensible evidence package your QA team can stand behind.
- Deliverables
- 05
- Days
- 90
- Yours
- 100%
Yours to keep — even if you choose not to move to a Year-1 license.
- 01
Workflow map
A documented, end-to-end map of your chosen GMP workflow.
- 02
Evidence pack
An inspection-defensible evidence package for that workflow.
- 03
Configured workflow templates
Templates configured to how your quality team actually works.
- 04
Director-level QA consulting
Founder- and director-level QA guidance through the sprint.
- 05
Validation enablement kit
The G-7 evidence-pack table of contents to accelerate your own validation.
The terms we won't bend
The Founding Partner Program is governed by a short list of commitments that protect your data, your validation ownership, and your name.
Verify, not validate
We verify under our SDLC. You own intended-use validation — that line never moves.
AI advisory + HITL only
MIRA is advisory, with a human in the loop on every GxP-critical decision. Never autonomous.
No token meter, no $/1K overage
AI is bundled across the pilot and the license. No metering, no per-use surprises.
Bundled validation accelerator
The validation enablement kit ships with the pilot, not as a paid add-on.
Data boundary you can name
US data in AWS US-East; India data in AWS Mumbai (DPDP-aware). Per-tenant isolation.
30-day clean-exit export
Leave at any time with a full export of your data and evidence within 30 days.
Per-use written reference approval
We never name you as a reference or case study without your written approval, each time.
What happens next
Application review
The founding team reviews your fit against the limited founding cohort — typically within 5 business days.
Phase 0 evidence-mapping call
We scope one GMP workflow and the evidence needed to make it inspection-defensible.
Founding Partner pilot
A 90 day paid pilot, 100% credited to your Year-1 license.
Only 2 founding partners will be signed by 31 Dec 2026. Founding-partner pilot credit is limited to the first two partners.
Verixa is the platform from Navira Quality Systems Pvt Ltd, the operating entity (US & India) and services arm. Sense7ai serves as the implementation partner. The Founding Partner Program is founder-led by Vimal Veereshwarayya, PhD, RAC.